Jonathan Spergel

Has grant

Professor

Children's Hospital of Philadelphia
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jonathan Spergel is a Professor at The Children's Hospital of Philadelphia, USA. His research focuses on eosinophilic esophagitis, atopic dermatitis, and the intersection of mental health and allergy. He has published recent articles analyzing therapeutic approaches for eosinophilic esophagitis and the implications of allergy treatments in pediatric and adult populations.

Recent Grants

Grant: Close

Toll-like Receptor Signaling in the Esophageal Epithelium

Open Date: 2010-05-15

Close Date: 2015-04-30

Grant: Close

Exploration into the Genetics of Food Allergy

Open Date: 2009-10-01

Close Date: 2010-09-01

Grant: Close

Pimecrolius on T cell Responses in Atopic March

Open Date: 2005-08-15

Close Date: 2010-01-31

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Objectives: There is limited longitudinal data on the impact of chronic therapy on the natural history of eosinophilic esophagitis [EoE], a chronic allergic disease of the esophagus. The purpose of this study was to evaluate if patients with well-controlled EoE were less likely to develop fibrostenotic complications. Methods: Subjects were identified from a database of pediatric EoE patients at the Children’s Hospital of Philadelphia started in 2000. Patients were then searched in adult medical records to identify patients who transitioned care. All office visits, emergency department (ED) visits and endoscopic, histologic, and imaging reports were reviewed for the primary outcome of strictures and the secondary outcomes of food impactions and dysphagia. Cox proportional hazard regression was performed for outcomes. Results: 105 patients were identified with mean follow up of 11.4 + 4.9 years. 52.3% (n=55) had a period of histologic disease control defined as > 2 consecutive endoscopies with histologic remission. These patients were less likely to develop strictures compared to patients who did not have a period of histologic control (HR 0.232; 95% CI 0.084-0.64, p=0.005). Patients who were diagnosed at younger ages were less likely to develop strictures. Presentation with dysphagia or impaction was associated with higher rate of stricture development. Conclusions: In this cohort study with > 10 years of follow up, children with EoE with a period of histologic disease control and diagnosed at younger ages were less likely to develop esophageal strictures. While this suggests histologic remission is associated with reduction of remodeling complications, additional prospective data with long-term follow up is needed.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Gary W. Falk

Hospital of the University of Pennsylvania

UNITED STATES
View details

Sayantani Sindher

Clinical Assistant Professor

Stanford University

UNITED STATES
View details

Melanie Ruffner

Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Albert J. Bredenoord

-

NETHERLANDS
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.